class = “cf”>
New types of coronavirus cases and virus-related victims continue to increase in Latin American countries.
Due to the epidemic, in the last 24 hours, 2 thousand 32 in Brazil, 221 in Mexico, 452 in Argentina, 689 in Colombia, 102 in Peru, 51 in Chile, 85 in Bolivia, 113 in Paraguay, Guatemala 49 people died in Honduras, 35 people and 39 people in Uruguay.
According to data from the Brazilian Ministry of Health, the number of deaths rose to 509,000 141 after 2,000 32 people lost their lives in the past 24 hours, and the total number of cases rose to 18 million 243,000 483 with the detection of 73 thousand 602 new cases.
The State of Sao Paulo, the commercial center of Brazil, stands out as “the region of the country most affected by the epidemic” with 3,648,000 202 cases and 124,000 606 deaths.
The number of people who have recovered in Brazil, the country with the highest number of deaths from Kovid-19 in the world after the United States, has been reported at 16 million 511,000 701.
FIRST SHIPMENT OF CUBAN-MADE COVID-19 VACCINE ABDALA HAS ARRIVED IN VENEZUELA
class = “cf”>
The first dose of the vaccine called “Abdala” developed by Cuba against the new type of coronavirus has arrived in Venezuela.
Venezuelan Vice President Delcy Rodriguez said in a statement that the first batch of the Abdala vaccine had arrived in the country as part of their deal with Cuba.
Emphasizing that they found Cuba’s fight against Kovid-19 admirable, Rodriguez said, “It’s an amazing vaccine with one of the best activities in the world. Today, Cuba teaches ethical, moral, scientific and technological lessons with vaccine candidates. blockade which may go against the will of the people. used his statements.
Rodriguez thanked Cuban President Miguel Diaz-Canel for his support in sending the vaccine to the country, arguing that the Abdala vaccine has shown more than 92 percent effectiveness.
In the Twitter post of the Cuban Center for Genetic Engineering and Biotechnology (CIGB) on June 22, it was stated that the effectiveness of the anti-Kovid-19 dose produced is 92.28 percent, “Cuba has 5 candidates. vaccines today, Soberana 02 with 62 percent effectiveness and 92 percent. With an efficacy rate of 28, says Abdala, these are already considered vaccines. Cuba will be the first country to self-vaccinate its population. he said.
Cuba announced on March 19 that one of the current vaccines has been approved for human trials and will be tested on approximately 48,000 people between the ages of 19 and 80.
This guide guides gastronomy enthusiasts